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Abstract
Background: Mesenchymal stem cells (MSC) represent a particularly attractive cell type for bone tissue engineering because
of their ex vivo expansion potential and multipotent differentiation capacity. MSC are readily differentiated towards mature
osteoblasts with well-established protocols. However, tissue engineering frequently involves three-dimensional scaffolds
which (i) allow for cell adhesion in a spatial environment and (ii) meet application-specific criteria, such as stiffness,
degradability and biocompatibility.
Methodology/Principal Findings: In the present study, we analysed two synthetic, long-term degradable polymers for their
impact on MSC-based bone tissue engineering: PLLA-co-TMC (ResomerH LT706) and poly(e-caprolactone) (PCL). Both
polymers enhance the osteogenic differentiation compared to tissue culture polystyrene (TCPS) as determined by Alizarin
red stainings, scanning electron microscopy, PCR and whole genome expression analysis. ResomerH LT706 and PCL differ in
their influence on gene expression, with ResomerH LT706 being more potent in supporting osteogenic differentiation of
MSC. The major trigger on the osteogenic fate, however, is from osteogenic induction medium.
Conclusion: This study demonstrates an enhanced osteogenic differentiation of MSC on ResomerH LT706 and PCL
compared to TCPS. MSC cultured on ResomerH LT706 showed higher numbers of genes involved in skeletal development
and bone formation. This identifies ResomerH LT706 as particularly attractive scaffold material for bone tissue engineering.
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Introduction
Human multipotent mesenchymal stem cells (MSC) are
multipotent stem cells and represent a particularly attractive
source for tissue engineering, because they are readily isolated and
expanded and can differentiate into several mature cell types, such
as adipocytes, chondrocytes, osteoblasts and myocytes [1,2 and
references therein]. Due to their mesenchymal origin and their
osteogenic differentiation capacity, MSC are particularly promis-
ing cells for bone replacement. Using a specific culture medium,
they can differentiate towards osteoblasts in vitro within three weeks
[3]. However, a biomaterial scaffold is required for bone tissue
engineering (BTE) to allow for immobilisation of cells in a spatial
structure. A variety of potential biomaterials exist, which are
cytocompatible for MSC, e. g. collagen, fibrin and non-oxide
ceramics [4–8]. For scaffolds in general, cyto- and biocompatibility
are the criteria of upmost importance and they need to meet
further specific application-dependant criteria. For BTE, a scaffold
should be osteoinductive or at least osteoconductive and has to be
long-term degradable to allow for an autologous replacement of
the transplanted area. Besides such specific requirements, a
fundamental bottleneck must be overcome to use MSC for BTE
– the adequate supply of the cells. This problem will become more
critical when aiming at engineering of bulk tissue to fill bone
defects after injury or elimination of tumors, particularly when
autologous bone production is desired. Such goals necessitate the
maintainance of large numbers of undifferentiated cells embedded
in biocompatible matrices to provide sufficient starting material.
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accessible, such as standard tissue culture poly(styrene) (TCPS),
Primaria
TM, poly(ethylene terephthalate) (PET) and TC plastics
biocoated with Matrigel
TM or single extracellular matrix proteins,
but given properties of the polymers make them ineligible for
tissue engineering. Further, frequently the animal origin of
biocoating products disqualify them from use in human clinical
applications. Currently, the published literature contains a large
number of studies in which stem cells are seeded on one or more
readily available materials but frequently such studies lack
systematic approaches to determine cell responses.
In our recent work we established a biomaterial test platform to
assess the compatibility of stem cells and biomaterials for tissue
engineering in a highly standardised and systematic manner. The
assessment of stem cell/biomaterial interactions is multifactorial
and requires a stringent analysis of parameters, such as material
surface and bulk properties, cytotoxicity, cell adhesion, cell
morphology, viability, proliferation, necrosis and apoptosis [5].
In our present study, we analysed in more detail the interactions of
MSC with two commercially available synthetic and resorbable
polymers of our panel of biomaterials, Poly(e-caprolactone) (PCL)
and poly[(L,L-lactide-co-trimethylene carbonate)7/3] (=PLLA-co-
TMC=ResomerH LT706).
PCL is a linear, semicrystalline, synthetic aliphatic homopolye-
ster, which has a degradation time of two to three years [9–11].
PCL is the most studied degradable polymer of the polyester
family [12] and is already approved by the Food and Drug
Administration for diverse applications in the human body.
Furthermore, PCL is currently under consideration for use in
bone tissue engineering [13–16].
In contrast, there is only poor knowledge on ResomerH LT706.
This linear and semi-crystalline poly-lactide-based polymer is
similar in chemistry to Suprathel, which is now used in clinical
trials for skin replacement after burns [17,18]. Further, poly(1,3-
trimethylene carbonate) copolymerised with D,L-lactide was
shown to be long-term biodegradable and biocompatible for soft
tissue engineering [19], but so far, polymers related to ResomerH
LT706 were not analysed with respect to their usefulness for bone
replacement. The random copolymer PLLA-co-TMC (ResomerH
LT706) is characterised by an intermediate-term degradation,
slower than poly(glycolic acid) (PGA), poly(D,L-lactide acid)
(PDLLA), and poly(glycolic acid-co-trimethylene carbonate)
(PGA-co-TMC), but faster than the long-term degradable PCL
[20–22]. Although, ResomerH LT706 has some advantages
regarding its mechanical properties and processing behavior, it is
used only in a few studies as potential scaffold for hard and soft
tissue engineering [23,24].
In the present study, we analysed the two polymers in
comparison to TCPS for their osteoinductive capacity and thus
for their potential use in BTE. Therefore, we seeded MSC on PCL
and ResomerH LT706 samples with defined, ultraflat topography
to exclude topography-dependant changes in cell adhesion,
morphology and proliferation. MSC adhered on both polymers
and showed only minor differences in morphology and viability.
When subjected to osteogenic induction medium (OIM), MSC
differentiated towards the osteoblastic fate. Alizarin red stainings,
realtime PCR, scanning electron microscopy (SEM) and energy-
dispersive X-ray spectroscopy (EDS) analysis revealed a similar
frequency of MSC-derived osteoblasts on the two polymers.
However, detailed studies on the molecular level including whole
genome expression analysis unravelled differences in the bioma-
terial-based propensity towards the osteogenic fate of MSC
supported by these two polymers.
Methods
Polymer synthesis
The polymers were produced as previously described [5] (Neuss
et al., 2008a).
Poly(e-caprolactone) (PCL)
PCL with a molecular weight of 80.000 g/mol was purchased
from Sigma-Aldrich GmbH (Germany). For PCL foils, 3 g of
granules were used. These granules were placed on TeflonH-
covered metal plates, the temperature was raised to 85uC and
maintained for 5 min. A load of 1000 kg was applied for 1 min at
85uC. After cooling down to room temperature, foils were then
washed several times with isopropanol (Fluka, Germany), aqueous
0.02 mM Tween 80 (Roth, Germany) and 8 M urea (Roth,
Germany) and then rinsed vigorously with demineralised water.
PCL samples were then dried in a vacuum oven for 24 h at 40uC.
Samples were placed in TCPS wells, stored at 4uC, and protected
from light. All steps were carried out under sterile conditions.
ResomerH LT706
Resomer type poly(L-lactic acid-co-trimethylene carbonate)
(=P(LLA-co-TMC; lactic acid-trimethylene carbonate ratio
70:30, LT706, 1.2–1.6 dL/g) was purchased from Boehringer
Ingelheim Pharma GmbH & Co. KG (Germany). Foils were
prepared by melt-pressing technique. Therefore, granules were
ground to powder in a cryo-mill and 1.2 g of the powder were
placed between TeflonH-covered metal plates. This was followed
by a 5 min incubation at 180uC. A load of 1000 kg was applied for
9 min. The P(LLA-co-TMC) foil was allowed to cool down to
room temperature, removed from the metal plates and further
processed as for as for PCL.
Coating of biomaterials with radiolabeled fibronectin and
vitronectin
100 ml of either fibronectin or vitronectin (100 mg diluted in
100 ml PBS; BD, Heidelberg, Germany) were mixed in a silanised
counter vial (3.5 ml volume) with 1 mlN a
125I solution (0.1 mCi;
3.7 MBq; 45 pmol; Amersham Europe, Freiburg, Germany) and
5 ml Chloramine-T solution (10 mg Chloramine-T trihydrate,
solved in 100 ml PBS) using a magnetic stir bar. After 5 min, the
incorporation of
125I into fibronectin and vitronectin was
measured by TCA precipitation. Therefore, a melted glass
capillary was immerged first into the iodinising mixture and then
into 200 ml of BSA solution (10% (m/m) BSA, 1% (m/m) NaI,
0.01% (m/m) NaN3). After vigorously mixing of the solution, an
aliquot of 10 ml was admixed with another 200 ml BSA solution.
Afterwards, 2 ml ice-cold 10% trichloroacetic acid was added.
The precipitated material consisting of BSA and target protein was
spinned down, separated from the supernatant and measured
using a gamma counter COBRA II Auto-Gamma (Packard,
Dreieich, Germany). To separate labelled protein from non-
incorporated iodine, the mixture was purified by gel filtration
using a SephadexH G-25 NAP
TM5 Column (Pharmacia Biotech
AB, Uppsala, Sweden). The column was equilibrated with PBS
before use. The identified radiolabelled proteins were stored at
220uC. Radiolabeled fibronectin and vitronectin were dissolved
in PBS and DMEM with 10% FCS in a concentration of 10 mg/
ml.
Radiolabeled protein adsorption study was carried out by
incubation of TCPS, ResomerH LT706 and PCL disc surfaces
with 2 ml of the different solutions, each with
125I-labeled
fibronectin or vitronectin (10 mg/ml), respectively. The activity
was adjusted to 100.000 cpm/500 ml (1.67 kBq/500 ml; 45.0 pCi/
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500 ml volume were measured using the gamma counter COBRA
II Auto-Gamma during a period of 3 min. After treatment of
biomaterial substrates with radiolabelled protein (incubation time
1 h) and subsequent washing, activity was measured using the
gamma counter during a period of 5 min.
Significant differences between samples were analysed using
student’s t-test for 10 independent measurements of each coating.
Isolation of human mesenchymal stem cells
Human mesenchymal stem cells (MSC) were isolated from
femoral head spongiosa of patients with total hip joint endopros-
thesis (TEP) after written consent was obtained from the patients.
The study was approved by the Ethics Committee of the
University Clinics, Aachen, Germany. MSC were characterised
as previously described [5–8,25; Fig. S2]. In brief, after rinsing the
spongiosa with stem cell medium, spongiosa was removed and the
remaining cell suspension was centrifuged for 10 min at 5006g.
Thereafter, the cell pellet was resuspended in stem cell medium
and cells were seeded in a T75 culture flask and cultured at 37uC
in a 21% O2 and 5% CO2 humidified atmosphere. After 24 hours,
non adherent (hematopoietic) cells were removed by medium
change. Mesenchymal stem cells were expanded in growth
medium (PAN Biotech, Aidenbach, Germany) consisting of 60%
DMEM low glucose, 40% MCDB-201, 2% FCS, 16ITS-plus
(insulin-transferrin-selenic acid+BSA-linoleic acid), 1 nM dexa-
methasone, 100 mM ascorbic-acid-2-phosphate, and 10 ng/ml
EGF. Medium was replenished every 3–4 days. At 80–90%
confluency, stem cells were trypsinised with stem cell trypsin
(CellSystems, St. Katharinen, Germany) and reseeded in a density
of 5,000 cells/cm
2 for optimal proliferation.
Differentiation of MSC towards osteoblasts
For osteogenic differentiation, MSC were seeded in a density of
3.1610
4 cells/cm
2 on TCPS and on foils of the two polymers PCL
and ResomerH LT706. Twenty-four hours after seeding, the
growth medium was replaced with osteogenic induction medium
(OIM) consisting of DMEM low glucose (PAA, Coelbe, Germany),
100 nM dexamethasone, 10 mM sodium b-glycerophosphate,
0.05 mM L-ascorbic-acid-2-phosphate (all Sigma, Steinheim,
Germany) and 10% FCS (PAN Biotech, Aidenbach, Germany).
Medium was changed every 2–3 days. After 21 days of osteogenic
differentiation, cells were fixed with 70% ethanol for 1 hour,
washed three times with demineralised water and then stained
with an Alizarin red solution (40 mM, pH 4.1, Sigma) for
10 minutes. Finally, cells were washed three times with PBS
(phosphate-buffered saline).
For quantification, the Alizarin red precipitates were solubilised.
Briefly, stained samples were incubated with 800 ml acetic acid
(10%) for 30 min. Then, supernatant was transferred into a 1.5 ml
tube and boiled for 10 min at 85uC, followed by a 5 min
incubation on ice. After centrifugation (15 min, 15,0006g), 500 ml
of the supernatant were transferred into another 1.5 ml tube and
mixed with 200 ml of 10% ammonium hydroxide. Samples of
150 ml were transferred into a 96 well microtiter plate and optical
density was measured at 405 nm using a standard ELISA reader.
P-value to detect statistically relevant differences for the
different biomaterials was calculated with student’s t-test (n=3
with two replicates each).
Scanning electron microscopy (SEM)
MSC/polymer biohybrids were fixed in 3% glutaraldehyde for
at least 24 hours, rinsed with sodium phosphate buffer (0.2 M,
pH 7.39, MERCK, Darmstadt, Germany) and dehydrated by
incubating consecutively in 30%, 50%, 70% and 90% acetone and
then three times in 100% acetone for 10 minutes. The biohybrids
were critical-point-dried in liquid CO2, and then sputter-coated
with a 30 nm gold layer. Samples were analysed using an
environmental scanning electron microscope (ESEM XL 30
FEG, FEI, PHILIPS, Eindhoven, The Netherlands) in a high
vacuum environment.
Energy-Dispersive X-ray Spectroscopy
Energy dispersive X-ray spectroscopy (EDS) is an analytical
technique used for element analysis samples. EDS was performed
on the XL 30 FEG scanning electron microscope (FEI,
Eindhoven, The Netherlands) using an EDAX Falcon Genesis
Spectrum 5.21 energy-dispersive X-ray spectroscopy system with
an ultrathin window liquid nitrogen cooled Si(Li) X-ray detector
(EDAX Inc. Mahwah, NJ, USA). For the EDS an accelerating
voltage of 20 kV was used.
Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR)
Total RNA was isolated using the RNeasy mini Kit according to
the manufacturers’ instructions (Qiagen, Hilden, Germany).
Reverse transcription was done with 1 mg of total RNA using
the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Darmstadt, Germany). PCR was as follows: denatur-
ation at 95uC for 1 min, annealing at 58uC (osteocalcin), 60uC
(alkaline phosphatase) for 1 min, extension at 72uC for 1 min (30
cycles), and a final extension at 72uC for 10 min. PCR products
were analysed by electrophoresis using a 2% agarose gel and
visualised with ethidium bromide. Primer sequences were used as
listed in Table 1.
RealTime PCR (RT-qPCR)
RealTime PCR was performed using SybrGreen and Taqman
technology. Briefly, 10 ml SybrGreen Master Mix (Applied
Biosystems, Darmstadt, Germany) was mixed with 1 ml (10 pg)
Primer forward, 1 ml (10 pg) Primer reverse, 6.8 ml water and
1.2 ml (60 ng) template. Then the samples were subjected to the
following program: initial denaturation at 95uC for 10 min,
followed by 40 cycles of denaturation at 95uC for 15 sec and
annealing/extension at 60uC for 1 min. Primer sequences and
sizes of amplicons are listed in table 1.
Whole Genome Expression Analysis
For whole genome expression analysis, MSC were seeded in a
density of 3.1610
4 cells/cm
2 on TCPS, ResomerH LT706 and
PCL and cultured for 21 days in growth medium (GM) or in
osteogenic induction medium (OIM). Cells at day 0 served as
control. Total RNA was isolated using the RNeasy micro Kit
according to the manufacturers’ instructions (Qiagen, Hilden,
Germany). The RNA quality was assessed using RNA 6000
NanoChips with the Agilent 2100 Bioanalyzer (Agilent; Santa
Clara, CA, USA). Probes for the GeneChipH Human Gene 1.0 ST
Arrays (Affymetrix, Santa Clara, CA, USA) were prepared and
hybridised to the arrays according to the Affymetrix GeneChipH
Whole Transcript (WT) Sense Target labeling Assay Manual.
Briefly, for each sample, 300 ng of total RNA was reverse
trancribed into cDNA using a random hexamer oligonucleotide
tagged with a T7 promoter sequence (59-GAATTGTAATAC-
GACTCACTATAGGGNNNNNN-39). After second strand syn-
thesis, double-stranded cDNA was used as template for amplifi-
cation with T7 RNA polymerase to obtain antisense cRNA.
Random hexamers were then used to reverse transcribe the cRNA
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fragmented by UDG (uracil DNA glycosylase) and APE1
(apurinic/apyrimidic endonuclease 1). Fragment size was checked
using the Agilent 2100 Bioanalyzer (fragment size between 50–
200 bp). Fragmented sense cDNA was biotin-labelled with TdT
(terminal deoxynucleotidyl transferase) and probes were hybrid-
ised to the GeneChipH Human Gene 1.0 ST Arrays at 45uC for
16 hours. Hybridised arrays were then washed and stained on
Fluidics Station 450 and scanned on a GeneChipH Scanner 3000
7G (both Affymetrix).
The image data were analysed with GCOS (Affymetrix). For
statistical analysis data were processed by R software (R
Development Core Team, 2005). Gene expression levels were
normalised with RMA algorithm [26]. Principal component
analysis (PCA) and hierarchical clustering were done on whole
genome transcripts by the R Stats Package [27]. Hierarchical
clustering was performed using Pearson correlation coefficient and
the Average linkage method. RankProd, a non-parametric
statistic, was employed for identification of differentially expressed
genes [28]. Transcripts with a fold change more than 2 and P-
value less than 0.01 between two conditions were considered as
being differentially expressed. Gene ontology (GO) and pathway
over-representation analysis was done using DAVID bioinfor-
matics resources [29].
Results
ResomerH LT706 and PCL enhance MSC differentiation
towards osteoblasts
In a previous study, we analysed MSC on a grid-based platform
in contact to different polymers to determine cytocompatibility of
polymers for future MSC-based tissue engineering applications
[5]. Now, MSC were cultured for 21 days either in growth
medium (GM) or in osteogenic induction medium (OIM) on two
of the cytocompatible, synthetic, biodegradable polymers, Reso-
merH LT706 and PCL, which are potentially osteoinductive. To
analyse the osteogenic differentiation, calcium accumulations were
visualised by Alizarin red staining (Fig. 1A), followed by dissolving
the dye and subsequent quantification of the staining (Fig. 1B).
Alizarin red stain residues were not retained by any of the
biomaterials (Fig. S3). As shown in Figure 1, polymers did not
induce osteogenic differentiation by themselve in GM and OIM
was always required to guide MSC into osteogenic fate. However,
although OIM was required to initiate osteogenic differentiation of
MSC on the two polymers, biomaterial properties influenced
calcium accumulations.
As shown in Figure 1, both polymers resulted in a stronger
alizarin red staining than TCPS. Further, the amount of calcium
accumulations on ResomerH LT706 was significantly higher, than
on TCPS and on PCL. Since the Alizarin red staining is an
indirect measure for osteogenic differentiation, we analysed the
differentiation in more detail. The ultrastructural analysis depicted
in Figure 1C illustrates the morphology of MSC on the two
polymers after a three-week culture period in GM or in OIM
(Fig. 1C). Our results show that although MSC morphology on the
two polymers differed during initial adhesion [5], MSC morphol-
ogy is identical on both polymers after 21 days of culture and
independent of the culture medium (GM vs. OIM). Higher
magnifications showed analogous particles densely covering the
biomaterial surfaces under differentiation conditions (OIM) on
both polymers, which were qualitatively identified as consisting of
calcium and phospate by EDS analysis (Fig. 1D). Such
calciumphosphate particles are indicative for an advanced
osteogenic differentiation of MSC on both polymers, ResomerH
LT706 and PCL. These results were confirmed by the expression
of osteogenic markers, such as alkaline phosphatase (which is
already expressed in unstimulated MSC), osteocalcin, bone
sialoprotein and the transcription factor Cbfa-1 after 21 days of
cultivation in OIM on the polymers (Fig. 2). By demonstrating (i)
positive Alizarin red staining and (ii) expression of standard
osteogenic markers on the RNA level, well-accepted standard
assays were performed to show osteogenic differentiation of MSC
on ResomerH LT706 and PCL. However, we reasoned that
conventional standard assays are not sufficient to comprehensively
investigate the osteogenic fate of MSC and thus we postulated,
that there might be differences in the quality of the MSC-derived
Table 1. Primer sequences for PCR and RT-qPCR.
Gene Sequence (59R39) Amplicon size
ACTB (ß-Actin) for TGGCACCACACCTTCTACAATGAGC
rev GCACAGCTTCTCCTTAATGTCACGC
400 bp
ALPL (alkaline phosphatase) for CCTCCTCGGAAGACACTCTG
rev AGACTGCGCCTGGTAGTTGT
238 bp
BGLAP (Osteocalcin) for CCCTCACACTCCTCGCCCTAT
rev TCAGCCAACTCGTCACAGTCC
246 bp
SFRP4 for GCGCACCAGTCGTAGTAATCC
rev TTCTTGGGACTGGCTGGTT
72 bp
PRELP for CAACAACAATAGCATCGAGAAAATCAAC
rev AGGTGTGGCACGTTCTCCAG
102 bp
COMP for CAGGGAGATCACGTTCCTGA
rev GGCCGGTGCGTACTGAC
77 bp
COL11A2 (Collagen 11) for GACTATCCCCTCTTCAGAACTGTTAAC
rev CTTCTATCAAGTGGTTTCGTGGTTT
131 bp
ELN (Elastin) for CCGCTAAGGCAGCCAAGTATGGA
rev AGCTCCAACCCCGTAAGTAGGAAT
275 bp
CCL2 for TGTCCCAAAGAAGCTGTGATCT
rev GGAATCCTGAACCCACTTCTG
84 bp
doi:10.1371/journal.pone.0023195.t001
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genome expression analysis to determine biomaterial-related
differences in osteogenic differentiation.
Whole genome expression analysis identifies specific
responses of ResomerH LT706
To determine the molecular events ongoing in MSC differenti-
ation on ResomerH LT706 and PCL, samples were analysed by
whole genome expression profiling. First, data were subjected to
principal component analysis (PCA, Fig. 3A) to discriminate related
samples(similargeneexpression)fromdistant samples(differentgene
expression). Figure 3A reveals the following information: the closer
the samples are, the more related is the gene expression pattern.
Thus, PCA demonstrated (i) general changes in gene expression
during the 21 day culture period (compare day 0 samples D1–3
cultured in GM, with all other samples), (ii) donor variations, since
donor3isseparatedfromdonors1 and2after21daysofculture,but
(iii) the same shift of all three donors occurred from culture in GM
and to culture in OIM (arrow in Fig. 3A). Hierarchical clustering
(Fig. 3B) of the same data set also revealed general changes in gene
expression over time (samples D1–3, grey dottet line), donor
variations as well as the shift between growth and differentiation
conditions (blue dottet lines vs. red dottet lines, respectively).
Additionally, this analysis also identified clustering of ResomerH
LT706 with TCPS, independent of donor and independent of
growth (GM) and differentiation (OIM) conditions (Fig. 3B). Thus
for each donor, ResomerH LT706 and TCPS consistently clustered
togetherwhen cultured inGMor inOIM (e.g. L3OIM/T3OIMor
L2 GM/T2 GM). In most cases, these neighboring clusters were
adjacent to the corresponding donor in the respective medium on
PCL (e.g. P3 GM is next to the L3 GM/T3 GM pair). Although the
Alizarin red staining was much stronger on ResomerH LT706 than
Figure 1. Osteogenic differentiation of MSC on polymers. A) Alizarin red staining of calcium accumulations on MSC, cultured on two polymers
and on tissue culture polystyrene (TCPS) for 21 days either in growth medium (GM) or in osteogenic induction medium (OIM). PCL=Poly(e-
caprolactone); LT706=ResomerH LT706; B) Quantification of Alizarin red staining via dissolving the dye and subsequent absorption measurement
(l=405 nm); n=3 with each 2 replicates; p.0.05; C) Electron microscopic view (SEM) of MSC, cultured for 21 days on ResomerH LT706 and PCL either
in GM or in OIM. From left to right: higher magnifications of the previous picture (1206up to 20.0006). White boxes in 20.0006magnification images
represent the area, which was subjected to EDS analysis (D); D) EDS Analysis of surfaces of ResomerH LT706 and PCL after a 21 day cultivation period
with MSC either in GM or in OIM. Prominent peaks of calcium and phosphate were detected in samples cultured in OIM, but not in samples cultured
in GM (compare y-axis scale).
doi:10.1371/journal.pone.0023195.g001
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expression seemed to be comparable to TCPS, both after culture in
GM and OIM. In contrast, PCL resulted in a different gene
expression profile compared to ResomerH LT706 and TCPS, but in
most cases, PCL samples were in direct proximity to TCPS and
ResomerH LT706 in the respective culture conditions (blue and red
dottet lines; Fig. 3B).
The results shown in Figure 3 indicate donor variations, as
expected for primary cells, but a similar influence on gene
expression by TCPS and ResomerH LT706, which was indepen-
dent of culture medium. Hence, we show that culture medium has
a stronger influence on MSC differentiation than the biomaterial
substrates. Alizarin red staining was stronger for PCL and
ResomerH LT706 compared to TCPS (Fig. 1A, B), yet PCL
Figure 2. Expression of osteogenic markers on RNA-level. A) Semiquantitative polymerase chain reaction (PCR) of the osteogenic markers
osteocalcin (246 bp) and alkaline phosphatase (238 bp) expressed in MSC on TCPS (d0) or cultured for 21 days in osteogenic induction medium (OIM)
on TCPS, ResomerH LT706 and PCL. ß-Actin (400 bp), loading control: DNA marker (100 bp ladder)=600 bp. Results of one representative experiment
out of three are shown. B) Microarray-data of three independent experiments (n=3) for osteocalcin, bone sialoprotein, Cbfa-1 and alkaline
phosphatase expressed in MSC on TCPS (d0) or cultured for 21 days in OIM on TCPS, ResomerH LT706 and PCL.
doi:10.1371/journal.pone.0023195.g002
Figure 3. Whole genome expression analysis of MSC, cultured for 21 days on TCPS, Resomer LT706 and PCL in growth medium
(GM) or in osteogenic induction medium (OIM). A) Principal component analysis (PCA) demonstrates donor variations, but all donors show the
same shift in position upon differentiation. Orange circles=MSC cultured for 21 days in GM; green circles=MSC cultured for 21 days in OIM; blue
circles=MSC expanded on TCPS in GM before differentiation experiment; T=TCPS; L=ResomerH LT706; P=PCL; D=Donor at day 0; 1,2,3=different
donors (n=3); PC1, 2, 3=Principal Component 1, 2 and 3; B) The dendrogram shows clustering of TCPS and ResomerH LT706, independent of donor
and independent of growth (GM) and differentiation (OIM) conditions. T=TCPS; L=ResomerH LT706; P=PCL; D=Donor at day 0; 1,2,3=different
donors (n=3); red dotted lines=OIM; blue dotted lines=GM.
doi:10.1371/journal.pone.0023195.g003
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ResomerH LT706 when compared to cells on TCPS. This analysis
describes the overall impact on the gene expression profile and the
identity of differentially expressed genes is discussed below.
Biomaterial substrate and culture medium impact on
gene expression of MSC and MSC-derived osteoblasts
ResomerH LT706, PCL and TCPS are semi-crystalline
polymers with a characteristic, textured structure and ultraflat
topography. Thus, the biomaterial surface physicochemistry could
be responsible for the specific changes in gene expression rather
than the biomaterial topography. Depending on the surface
physicochemistry, proteins adsorb to the biomaterial, yet the
underlaying mechanisms are still not fully understood. In this
context we emphasize that cells do not adhere directly to
biomaterial surfaces but rather adhere to a protein layer, which
promptly adsorbes to biomaterials, when exposed to cell culture
medium. Within the two cell culture media (GM and OIM) the
composition of proteins is quite different, which presumably results
in different protein layers on the biomaterial surfaces when
cultured either in GM or in OIM (2% FCS vs. 10% FCS,
respectively). Further, the amount of adsorbed proteins and the
orientation of active groups of the adsorbed proteins could differ
depending on the biomaterial physicochemistry. Accordingly, this
leads to different cell behaviours on the very same biomaterial,
when cultured in different media. However, within the same
culture medium, different biomaterials can influence cells in
different ways.
The heatmap of expression data shown in Figure 4A demon-
states the impact of biomaterial substrate and culture medium on
gene expression of MSC and MSC-derived osteoblasts. We detect
two main gene expression pattern: one is representative for cells
cultured in GM (Fig. 4A, right) and one for cells cultured in OIM
(Fig. 4A, left), regardless of the biomaterial substrate meaning that
the impact of the growth medium is higher than the impact of the
biomaterials. However, within the two groups, MSC cultured on
ResomerH LT706 and TCPS cluster together, while PCL form a
separate branch, which is in line with the results depicted in
Figure 3. Again, these results demonstrate the influence of culture
medium on MSC, which is more prominent than the influence of
biomaterial substrates.
As shown by hierarchical clustering (Fig. 3 and Fig. 4A), MSC
on ResomerH LT706 and TCPS show a similar gene expression
pattern and this translates into a small number of differentially
expressed genes. As described above, MSC do not attach directly
to the biomaterial surface, but to the protein layer, which covers
the biomaterials after exposure to the cell culture medium. As
shown in Figure S1, fibronectin (FN) and vitronectin (VN), two
main components of serum involved in cell adhesion, are adsorbed
to TCPS, ResomerH LT706 and PCL. While the amount of
Figure 4. Impact of the biomaterials and culture media on MSC at growth and differentiation state. A) Heatmap representation of
medium-dependant effects on MSC, cultured for 21 days on TCPS, ResomerH LT706 and PCL, either in growth medium (GM) or in differentiation
medium (OIM). T=TCPS; L=ResomerH LT706; P=PCL; D=donor at day 0; 1,2,3=different donors (n=3); B) Heatmap representation of biomaterial
impact on differentiation state (MSC cultured in OIM after 21 days). Genes boxed by a discontinuous line are similarly expressed in TCPS and
ResomerH LT706 (upper box) or in ResomerH LT706 and PCL (lower box). Genes highlighted in orange were analysed by RT-qPCR. T=TCPS;
L=ResomerH LT706; P=PCL; 1,2,3=different donors; C) RT-qPCR for SFRP4, PRELP, COMP, COL11A1, ELN and CCL2 to confirm gene array results of
Figure 4C. Expression of genes was normalised to the reference gene ß-actin. TCPS was used as calibrator. n=3.
doi:10.1371/journal.pone.0023195.g004
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cm
2), ResomerH LT706 is covered with approx. 150 ng FN/cm
2.
However, the relation between absorbed FN and VN is the same
for TCPS and ResomerH LT706 (fibronectin to vitronectin
ratio=1.2), while the relation between FN and VN on PCL is
1.04. These results were not significantly different either when we
used a buffer system including FN and VN or serum-containing
medium including FN and VN (not shown). Thus, the ratio of
adsorbed FN to adsorbed VN might be key to MSC gene
expression.
Finally, differentially regulated genes of MSC cultured on
ResomerH LT706, PCl and TCPS under differentiation conditions
(OIM) were subjected to hierarchical cluster analysis and data
depicted in heat map format (Fig. 4B). This analysis shows that
ResomerH LT706 and TCPS clustered together and PCL formed
a distinct cluster. Some donor variations were also seen in this heat
map representation, which is in line with the PCA analysis
(Fig. 3A). In addition, this analysis identified a large cluster of
genes, with a similar expression pattern in ResomerH LT706 and
TCPS (Fig. 4B, upper boxed area). Furthermore, we also identified
genes that showed a similar expression in MSC on ResomerH
LT706 and PCL, but are differentially expressed in MSC on
TCPS, e.g. CCL2 (Fig. 4B, bottom boxed area).
Well-known osteogenic marker genes were expressed in MSC
cultured on all three biomaterials (TCPS, ResomerH LT706 and
PCL; compare Fig. 2). Thus, the expression and interaction of
other genes involved in osteogenesis and chondrogenesis (Fig. 4C)
might be important to regulate MSC differentiation towards
osteoblasts either via osteogenesis or ossification on these
biomaterials. To further support the data of whole genome gene
expression analysis, we perfomed quantitative PCR. Therefore, we
choosed a panel of genes involved in skeletal development and
osteogenic differentiation, highlighted in orange in Figure 4B. As
shown in Figure 4C, gene expression of MSC-derived osteoblasts
was influenced by biomaterial substrates or – by keeping in mind
the results on FN and VN described above - by serum proteins
which are adsorbed to the biomaterials before cell attachment.
Secreted frizzled related protein 4 (SFRP4), Proline/arginine-
rich end leucine-rich repeat protein (PRELP), cartilage oligomeric
matrix protein (COMP), a1 XI collagen (COL11A1) and elastin
(ELN) expression is higher in MSC cultured in OIM on ResomerH
LT706 and TCPS in comparison to PCL (Fig. 4C). Chemokine
(C-C motif) ligand 2 (CCL2) expression is increased under
differentiation conditions on ResomerH LT706 and PCL (compare
Fig. 4C with Fig. 4B).
Gene ontology (GO) overrepresentation analysis detects
biological categories related to skeletal development
and bone formation
Gene functions are described in a controlled vocabulary format
referred to as gene ontology (GO; www.geneontology.org) and
thus differentially regulated genes between the three biomaterials
cultured in GM and OIM were subjected to GO overrepresen-
tation analysis, respectively. The main categories of the two
culture conditions are shown for MSC cultured on ResomerH
LT706, PCL and TCPS in GM (Table 2) and for MSC cultured
on ResomerH LT706, PCL and TCPS in OIM (Table S2). Some
categories exist in both lists, like developmental process, system
development and extracellular region. However, bone specific
categories, such as bone remodelling, calcium ion binding, bone
mineralisation, ossification and biomineral formation are – as
expected - not found in the GO list for the growth conditions
(GM), but confined to the GO list for the differentiation conditions
(OIM).
Discussion
MSC are the natural precursor cells of mesenchymal tissue,
such as fat, bone and cartilage. They reside in a tissue-specific
niche, awaiting signals for tissue regeneration, if necessary [30]. In
the last decade, MSC were extensively investigated for their
usefulness in bone tissue engineering and diverse scaffold materials
were suggested to provide an appropriate three-dimensional
environment [31–34]. Promising tissue-engineered constructs are
already on the way from bench to bedside [35]. However, the
impact of scaffolds on osteogenic differentiation on the molecular
level was rarely analysed and restricted to some well-known
osteogenic marker genes, such as alkaline phosphatase, runt
related transcription factor 2, type 1 collagen, bone sialoprotein
and osteocalcin [34,36].
In the present study, we initially investigated a panel of different
polymers for their influence on the osteogenic differentiation of
MSC. We then focused on the two most prominent synthetic
polymers ResomerH LT706 and PCL. Both polymers are linear,
semi-crystalline polyesters, which are hydrolytically or enzymat-
ically degradable. ResomerH LT706 is degradable within 8–12
month, while PCL is long-term degradable (.24 month) [20].
PCL is an FDA proved and widely used engineering polymer
with excellent physical, chemical and mechanical properties
[37,38]. It is already analysed in the context of bone tissue
engineering, either as pure PCL [39], as composite scaffold e.g.
together with hydroxyapatite or calcium phosphate [40,41] or
modified with a peptide layer such as RGD [16]. All of these
studies suggest PCL as suitable scaffold material for bone tissue
engineering.
In contrast, ResomerH LT706 is a relatively novel and less-
investigated synthetic polymer, described for the first time as
Poly(L-lactide-co-TMC) in 2005 by Pospiech and coworkers [42].
Materials with related chemistry are shown to be biodegradable
and biocompatible for soft tissue engineering [19] and used in
clinical trials for skin replacements [17,18]. However, our recent
work showed that a prediction of cell behaviour on a chemically
related material is not possible [5]. ResomerH LT706 was not
analysed in the context of bone tissue engineering or osteogenic
differentiation of MSC so far.
We compared the osteogenic differentiation of MSC on the two
elastomeric and long-term degradable synthetic polymers Reso-
merH LT706 and PCL. TCPS served as control. Our XPS data
revealed that the two polyesters ResomerH LT706 and PCL do not
differ qualitatively in their elemental composition, but quantita-
tively, indicated by the C/O ratio. The C/O-values for ResomerH
LT706 and PCL are 1.7 and 2.6, respectively (Table S1). Further,
XPS analysis of our biomaterial surfaces shows that PCL contains
less oxygen atoms than ResomerH LT706, indicating PCL as more
hydrophobic than ResomerH LT706. However, contact angle
measurements detected the opposite, with ResomerH LT706 being
more hydrophobic than PCL with the corresponding contact
angles of 75u and 69u, respectively. The higher hydrophobic
characteristic of ResomerH LT706 is a result of its molecular
structure. ResomerH LT706 consists of 68–72% L-lactide units
and thus includes sterically demanding and hydrophobic methyl
groups in high frequencies at the surface. In contrast, PCL only
includes methylene groups in its backbone. TCPS – in contrast to
polystyrol – does not consist of phenyl rings, but also includes
surface modifications (established by physical plasma) of hydroxyl-,
carboxyl- and amino-groups on the surface and a contact angle of
only 54u (Table S1).
To allow for an adequate adhesion of MSC on our substrates
(TCPS, ResomerH LT706, PCL and TCPS), an initial adsorption
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(GM)
Term Count P-Value
Biological Process
GO:0006817,phosphate transport 5 114E-06
GO:0007275,multicellular organismal development 18 237E-06
GO:0032502,developmental process 21 288E-06
GO:0048856,anatomical structure development 16 859E-06
GO:0015698,inorganic anion transport 5 148E-05
GO:0006820,anion transport 5 275E-05
GO:0048513,organ development 12 310E-05
GO:0006029,proteoglycan metabolic process 3 332E-05
GO:0022610,biological adhesion 8 437E-05
GO:0007155,cell adhesion 8 437E-05
GO:0048731,system development 13 541E-05
GO:0016055,Wnt receptor signaling pathway 4 620E-05
GO:0051216,cartilage development 3 952E-05
GO:0032501,multicellular organismal process 21 155E-04
GO:0030217,T cell differentiation 3 190E-04
GO:0001501,skeletal development 4 196E-04
GO:0046457,prostanoid biosynthetic process 2 273E-04
GO:0001516,prostaglandin biosynthetic process 2 273E-04
GO:0001502,cartilage condensation 2 303E-04
GO:0006811,ion transport 7 318E-04
GO:0006954,inflammatory response 4 324E-04
GO:0002250,adaptive immune response 3 364E-04
GO:0002460,adaptive immune response based on somatic recombination of immune receptors 3 364E-04
GO:0006693,prostaglandin metabolic process 2 422E-04
GO:0006692,prostanoid metabolic process 2 422E-04
GO:0030098,lymphocyte differentiation 3 427E-04
GO:0030199,collagen fibril organization 2 451E-04
GO:0016525,negative regulation of angiogenesis 2 568E-04
GO:0042110,T cell activation 3 671E-04
GO:0009611,response to wounding 4 738E-04
GO:0002521,leukocyte differentiation 3 757E-04
GO:0046456,icosanoid biosynthetic process 2 798E-04
GO:0006955,immune response 5 894E-04
GO:0006690,icosanoid metabolic process 2 966E-04
Molecular Function
GO:0005201,extracellular matrix structural constituent 7 312E-10
GO:0030020,extracellular matrix structural constituent conferring tensile strength 5 159E-08
GO:0005515,protein binding 29 150E-05
GO:0005198,structural molecule activity 7 115E-04
GO:0005539,glycosaminoglycan binding 3 245E-04
GO:0005488,binding 42 280E-04
GO:0030247,polysaccharide binding 3 291E-04
GO:0005125,cytokine activity 4 317E-04
GO:0001871,pattern binding 3 341E-04
GO:0005102,receptor binding 6 509E-04
GO:0005506,iron ion binding 4 774E-04
GO:0008083,growth factor activity 3 828E-04
Cellular Component
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fibronectin (FN) and vitronectin (VN), is crucial, since in general,
the less adsorbed proteins the less cell adhesion is mediated. As
shown in our adsorption studies with radiolabelled FN and VN
(Figure S1), ResomerH LT706 is covered with the highest amount
of FN proteins, compared to TCPS and PCL. Further, the ratio of
FN to VN on ResomerH LT706 is comparable to that on TCPS,
albeit absolut values are higher for ResomerH LT706. It is known
that extracellular matrix (ECM) proteins are involved in cell
adhesion not only by their own presence, but also by their relation
to other ECM proteins [43,44]. This ratio of different ECM
proteins then can result in differences in cell adhesion, morphol-
ogy, proliferation, gene expression as well as ECM secretion. The
similar ratio of FN/VN on ResomerH LT706 and TCPS
compared to PCL (1.2 and 1.04, respectively) might be the reason
for a comparable initial adhesion and morphology of MSC, which
differs from that on PCL, where the cells are more roundish after
24 h of incubation [5]. However, MSC proliferation within 7 days
after cell seeding was comparable for TCPS, ResomerH LT706
and PCL [5] and cell morphology was identical after 21 days of
culture in GM or OIM (Fig. 1C). Although we detected a
comparable proliferation of MSC on all three substrates,
osteogenic differentiation capacity was different.
In the present study, we found that both ResomerH LT706 and
PCL cyused stronger alizarin red stainings compared to TCPS,
which however was most significant for ResomerH LT706. The
fact that the alizarin red staining is stronger for ResomerH LT706
than for PCL, though MSC proliferation is comparable on both
polymers [5], suggests that ResomerH LT706 is more potent in
supporting osteogenic differentiation than PCL. A positive Alizarin
red staining is indicative for osteogenic MSC fate, but stains only
calcium accumulations and thus provides only indirect evidence.
We were thus interested in the quality and the molecular
mechanisms underlying osteogenic differentiation of MSC on
ResomerH LT706 and PCL. As initial step in this direction we
performed whole genome expression analysis using Affymetrix
gene arrays. Bioinformatic tools then unravelled (i) donor
variations as expected for primary cells, (ii) clusters of samples
representative for MSC cultured in growth medium (GM) or in
osteogenic induction medium (OIM), indicating a stronger
influence of culture medium than of biomaterial substrates, and
(iii) clusters of TCPS and ResomerH LT706 under growth (GM)
and differentiation conditions (OIM), demonstrating a similar
influence on MSC gene expression. Pairs of TCPS and ResomerH
LT706 were detected in all bioinformatic analysis. Although both
materials are quite different e.g. in surface chemistry (polarity,
hydrophobicity, surface charge) and bulk properties (e.g. stiffness),
the impact on gene expression related to osteogenesis of MSC is
comparable. Yet, TCPS is not useful for bone tissue engineering
because of its fabrication characteristics based on its chemical and
physical properties. Again this supports our recent study, showing
that related biomaterials do not inevitably result in the same
cellular response, while unrelated materials might do [5]. The heat
map in Figure 4B shows that most genes were expressed on a
similar level in MSC cultured on TCPS and ResomerH LT706,
while only a few genes were differentially expressed on these two
materials.
We extended our gene array results by RT-qPCR of the six
genes secreted frizzled related protein 4 (SFRP4), Proline/
arginine-rich end leucine-rich repeat protein (PRELP), cartilage
oligomeric matrix protein (COMP), a1 XI collagen (COL11A1),
elastin (ELN) and chemokine (C-C motif) ligand 2 (CCL2)
(Fig. 4C).
For all of these genes published data suggest a role in skeletal
development or osteogenic differentiation. SFRP4 is expressed in
periosteum and bone tissue but overexpression of SFRP4
suppresses osteoblast proliferation [45]. PRELP is a connective
tissue matrix protein, which is expressed in cartilage and in
osteoblasts [46]. COMP is involved in skeletal development and
osteoblast differentiation [47] and detectable in MG-63 cells, an
osteoblast cell line. Mutations of COMP are related to specific
diseases, such as pseudoachondroplasia and multiple epiphyseal
dysplasia [48]. COL11A1 is essential for normal skeletal
development, but has to be suppressed for terminal osteoblast
differentiation [49]. Elastin degradation products promote
osteogenic differentiation and elastin-related calcification is
suggested to be involved in tissue repair processes [50]. Finally,
CCL2 - which is known as chemokine for the recruitment of cells
of the immune system, such as monocytes - is secreted by MSC
and this secretion increases the differentiation into mature
osteoblasts [51].
Compared to MSC cultured on TCPS and ResomerH LT706,
all genes showed lower expression in MSC cultured on PCL,
except CCL2. Since all these genes are involved in skeletal
development and bone formation, our results suggest ResomerH
LT706 as more suitable for bone tissue engineering than PCL.
Term Count P-Value
GO:0005576,extracellular region 31 317E-16
GO:0044421,extracellular region part 30 386E-16
GO:0005578,proteinaceous extracellular matrix 13 405E-13
GO:0005615,extracellular space 26 531E-13
GO:0031012,extracellular matrix 13 553E-13
GO:0044420,extracellular matrix part 7 532E-09
GO:0005581,collagen 5 466E-08
GO:0005604,basement membrane 4 103E-05
GO:0030935,sheet-forming collagen 2 206E-04
GO:0005587,collagen type IV 2 206E-04
The ‘Count’ column refers to the number of transcripts in the respective catergory.
The ‘P-Value’ column shows the value of Fisher’s exact t-test, used by DAVID to measure the enrichment in annotation terms.
doi:10.1371/journal.pone.0023195.t002
Table 2. Cont.
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ResomerH LT706 and PCL. Alizarin red stainings and expression
of conventional osteogenic transcripts show that both biomaterials
support osteogenic differentiation fate. However, whole genome
expression analysis revealed differences in gene expression and
genes involved in skeletal development and bone formation are
more expressed at higher levels in MSC cultured on ResomerH
LT706. Thus, this novel, long-term degradable and osteoconduc-
tive synthetic polymer is suggested as particularly attractive
scaffold material for bone tissue engineering with superior
properties compared to the currently being used material PCL.
The in vitro transformation of MSC on ResomerH LT706 to more
osteogenic genotypes might also translate to phenotypes. This
hypothesis has to be verified in future in vivo models.
Supporting Information
Figure S1 Adsorption of serum proteins fibronectin
(FN) and vitronectin (VN) on biomaterial surfaces. TCPS,
ResomerH LT706 and PCL are coated with radiolabelled FN and
VN. Adsorbed proteins are quantified using a Gammacounter
COBRA II device (ng adsorbed protein per cm
2 biomaterial
surface). Mean values of 10 independent measurements per
coating are shown; *p,0.01 compared to TCPS.
(JPG)
Figure S2 Characterisation of MSC according to minimal
criteria of the International Society for Cellular Therapy.
MSC can be differentiated according to standard protocols towards
adipocytes, osteoblasts and chondrocytes (A) and express a specific
surface pattern with positivity for CD 73, CD90 and CD105 and
without expression of hematopoietic markers, such as CD4 and
CD14.
(JPG)
Figure S3 Control staining of polymers without stem
cells after incubation in OIM. The polymers do not bind
Alizarin red stain after 21 days of incubation in OIM.
(JPG)
Table S1 Characterisation of biomaterials.
(DOC)
Table S2 GO list with genes differentially expressed in
MSC cultured on TCPS, ResomerH LT706 and PCL
during differentiation conditions (OIM).
(DOC)
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